14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
BMA vs SYBT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Stock Yards Bancorp, Inc. (SYBT) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BMA carries a Unified Composite Score of 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin), whereas SYBT carries 40.7/100 (SELL) at $78.03 (13.6x Forward P/E, 48.5% operating margin).
Defensive Composite Rating Caution: Although SYBT compares more favorably head-to-head, both BMA (39.3/100 SELL) and SYBT (40.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: BMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7); meanwhile SYBT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMA vs SYBT. Trailing 12-month operating profitability (BMA 18.0% vs SYBT 48.5%) and valuation multiples (BMA 3.1x vs SYBT 13.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Banks - Regional value chain with $3.6B market capitalization and 18.0% operating margin.
OpEx & R&D Reinvestment80.7% of Rev ($2.81B)
90D Engineering Disclosures0 Published
SYBT Moat ProfileHigh-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $2.5B market capitalization and 48.5% operating margin.
OpEx & R&D Reinvestment51.5% of Rev ($226M)
90D Engineering Disclosures0 Published
Investor FAQ BMA vs SYBT Key Questions & Quantitative Answers
As of Nov 16, 2026, Stock Yards Bancorp, Inc. (SYBT) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BMA carries a Unified Composite Score of 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin), whereas SYBT carries 40.7/100 (SELL) at $78.03 (13.6x Forward P/E, 48.5% operating margin). Defensive Composite Rating Caution: Although SYBT compares more favorably head-to-head, both BMA (39.3/100 SELL) and SYBT (40.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: BMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7); meanwhile SYBT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SYBT leads the Growth & Scale pillar: BMA posts +1.2% YoY revenue growth and +3.5% YoY earnings growth on $3.48B TTM revenue (98.7% gross margin, 18.0% operating margin), compared with SYBT at +19.8% YoY revenue growth and +13.8% YoY earnings growth on $438M TTM revenue (100.0% gross margin, 48.5% operating margin). On trailing 12-month operating scale, BMA generates $3.48B in USD-normalized revenue versus $438M for SYBT. In operating R&D and SG&A reinvestment, BMA deploys 80.7% of Rev ($2.81B) (0 90-day corporate R&D disclosures) versus 51.5% of Rev ($226M) (0 disclosures) for SYBT.
BMA screens cheaper on headline valuation multiples. BMA trades at 3.1x Forward P/E, 11.4x Trailing P/E, 0.47x PEG, and 1.0x EV/Revenue (unreported cash flow margin), whereas SYBT trades at 13.6x Forward P/E, 15.3x Trailing P/E, 1.33x PEG, and 5.6x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BMA (7.1% ROE) versus SYBT (13.6% ROE) capital efficiency.
In options market volatility and institutional positioning, BMA carries 77.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 42% Vol realized risk). By comparison, SYBT carries 34.2% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 27% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.